Ultrasound-Guided Tibial Nerve Block vs. Local Corticosteroid Injection in Recalcitrant Plantar Fasciitis Treatment

NCT ID: NCT04029389

Last Updated: 2019-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

78 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-01

Study Completion Date

2020-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomized controlled study to search for the efficiency of tibial nerve block vs local corticosteroid injection of the plantar fascia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Three groups will be formed. After ESWT therapy, if the patients still suffer from pain (\> 5 points, visual analog scale(0-10points), participants will be included in the study. One group will receive conversational therapy. Second group will be treated with local corticosteroid injection. And third group will be treated with tibial nerve block. Before-treatment, after one week, after six weeks and after 3 months evaluation of the patients will be performed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Plantar Fascitis Tibial Nerve Injections Ultrasonography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Recalcitrant Plantar Fasciitis/Conservational

After ESWT therapy patients suffer from extreme pain will recieve only conservational therapy (26 patients)

Group Type EXPERIMENTAL

Conservational therapy

Intervention Type OTHER

Only exercise and foot insoles

Recalcitrant Plantar Fasciitis/Local

After ESWT therapy patients suffer from extreme pain will receive local steroid injections

Group Type EXPERIMENTAL

Injection

Intervention Type DEVICE

Local corticosteroid injection

Recalcitrant Plantar Fasciitis/Tibial nerve

After ESWT therapy patients suffer from extreme pain will receive tibial nerve block

Group Type EXPERIMENTAL

Tibial nerve block

Intervention Type DEVICE

Tibial nerve block

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Injection

Local corticosteroid injection

Intervention Type DEVICE

Tibial nerve block

Tibial nerve block

Intervention Type DEVICE

Conservational therapy

Only exercise and foot insoles

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Recalcitrant plantar Fasciitis

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gaziosmanpasa Research and Education Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mehmet Akif GÜLER

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ebru Yalçınkaya

Role: STUDY_DIRECTOR

Gaziosmanpasa Taksim Training and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gaziosmanpasa Taksim Training and Research Hospital

Istanbul, İ̇stanbul, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mehmet Akif A Guler, M.D.

Role: CONTACT

+905054930098

Zeynel Karakullukcuoglu, M.D.

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mehmet Akif Guler

Role: primary

5054930098

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GaziosmanpasaTREH8

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.